Prostate Cancer - Results from #25480

Differences in frequency of ERG oncoprotein expression between index tumors of Caucasian and African American patients with prostate cancer - Abstract September 26, 2012

PCA3 score and prostate cancer diagnosis at repeated saturation biopsy. Which cut-off: 20 or 35? - Abstract September 26, 2012

Assessment of rates of lymph nodes and lymph node metastases in periprostatic fat pads in a consecutive cohort treated with retropubic radical prostatectomy - Abstract September 26, 2012

Cabazitaxel: A novel drug for hormone-refractory prostate cancer - Abstract September 26, 2012

Advantages of robot-assisted laparoscopic radical prostatectomy in obese patients: Comparison with the open procedure - Abstract September 26, 2012

Differences in postoperative pathological outcomes between prostate cancers diagnosed at initial and repeat biopsy - Abstract September 26, 2012

Predictors of Gleason score (GS) upgrading on subsequent prostatectomy: A single institution study in a cohort of patients with GS 6 - Abstract September 26, 2012

Intraductal carcinoma of the prostate: Precursor or aggressive phenotype of prostate cancer? - Abstract September 26, 2012

Superior vena cava syndrome as a presentation of metastatic prostate cancer - Abstract September 25, 2012

Farming, reported pesticide use, and prostate cancer - Abstract September 25, 2012

Genetic heterogeneity in Finnish hereditary prostate cancer using ordered subset analysis - Abstract September 25, 2012

Tumour characteristics, oncological and functional outcomes in patients aged ≥ 70 years undergoing radical prostatectomy - Abstract September 25, 2012

PSA testing in general practice - Abstract September 25, 2012

Early diagnosis and treatment is crucial for neurological recovery after surgery for metastatic spinal cord compression in prostate cancer - Abstract September 25, 2012

Denosumab for the treatment of cancer therapy-induced bone loss and prevention of skeletal-related events in patients with solid tumors - Abstract September 25, 2012

Cost-effectiveness analysis of stereotactic body radiation therapy versus intensity-modulated radiation therapy: An emerging initial radiation treatment option for organ-confined prostate cancer - Abstract September 25, 2012

Docetaxel plus prednisone versus mitoxantrone plus prednisone as first-line chemotherapy for metastatic hormone-refractory prostate cancer: Long-term effects and safety - Abstract September 25, 2012

African American prostate cancer survivors' treatment decision-making and quality of life - Abstract September 24, 2012

Transrectal biopsy scheme can predict incorrect histological grading in prostate cancer - Abstract September 24, 2012

Completeness of prostate cancer staging in the Danish Cancer Registry, 2004-2009 - Abstract September 24, 2012

Page 1275 of 1473